Vital Farms director buys 6,000 company shares

Vital Farms, Inc. director William B. Cyr bought 6,000 shares of common stock in an open-market purchase at a weighted average price of $8.52 per share.

Rhea-AI Filing Summary

Vital Farms, Inc. director William B. Cyr bought 6,000 shares of common stock in an open-market purchase at a weighted average price of $8.52 per share. After this transaction, he directly holds 13,794 shares.

The shares were bought on May 14, 2026 across multiple trades at prices ranging from $8.47 to $8.57 per share, according to the weighted-average pricing footnote.

Insider Trade Summary

Net Buyer: 6,000 shares

Net Buy 1 txn

Insider Cyr William B.

Role Director

Bought 6,000 shs ($51K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	6,000	$8.52	$51K

Holdings After Transaction: Common Stock — 13,794 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.47 to $8.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Key Figures

Shares purchased: 6,000 shares Weighted average price: $8.52 per share Post-transaction holdings: 13,794 shares +1 more

4 metrics

Shares purchased 6,000 shares Open-market purchase of common stock on May 14, 2026

Weighted average price $8.52 per share Average price for the 6,000 shares purchased

Post-transaction holdings 13,794 shares Total common stock directly owned after the transaction

Trade price range $8.47–$8.57 per share Range of individual transaction prices on May 14, 2026

Key Terms

open-market purchase, weighted average price, Form 4/A

3 terms

open-market purchase financial

"The transaction is described as an open-market purchase of common stock."

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported is a weighted average price for multiple trades."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Form 4/A regulatory

"The insider transaction is disclosed in an amended Form 4/A filing."

Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Vital Farms (VITL) disclose in this Form 4/A?

Vital Farms (VITL) disclosed that director William B. Cyr completed an open-market purchase of common stock. He bought 6,000 shares on May 14, 2026, reflecting personal share accumulation rather than a sale or derivative exercise.

How many Vital Farms (VITL) shares did William B. Cyr buy and at what price?

Director William B. Cyr purchased 6,000 shares of Vital Farms (VITL) common stock. The weighted average purchase price was $8.52 per share, with individual trade prices ranging between $8.47 and $8.57 during the transaction date.

What are William B. Cyr’s total Vital Farms (VITL) holdings after this transaction?

Following the reported open-market purchase, director William B. Cyr directly owns 13,794 shares of Vital Farms (VITL) common stock. This figure reflects his position immediately after acquiring the additional 6,000 shares on May 14, 2026, as shown in the filing.

Was the Vital Farms (VITL) insider trade an open-market purchase or another type?

The transaction reported for Vital Farms (VITL) was an open-market purchase of common stock. The filing classifies it with transaction code P, described as a purchase in the open market or a private transaction, not an option exercise or gift.

What price range did the Vital Farms (VITL) insider pay for the purchased shares?

The filing notes a weighted average price of $8.52 per share. According to the footnote, the 6,000 Vital Farms (VITL) shares were bought in multiple trades at prices ranging from $8.47 to $8.57 inclusive on the transaction date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 04:55 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cyr William B.

(Last) (First) (Middle)

C/O VITAL FARMS, INC.

3601 SOUTH CONGRESS AVENUE, SUITE A100

(Street)

AUSTIN TEXAS 78704

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/18/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/14/2026		P		6,000	A	$8.52(1)	13,794	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.47 to $8.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Remarks:

This Form 4/A amends the Form 4 filing dated May 18, 2026, solely to amend the footnote in this report to clarify that the transaction referred to in Table I was a purchase.

	/s/ Francis Cullo, Attorney-in-Fact	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)